+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Radiopharmaceuticals and the Medicines Act



Radiopharmaceuticals and the Medicines Act



Nuclear Medicine Communications 8(2): 67-68




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 068584837

Download citation: RISBibTeXText

PMID: 3587791

DOI: 10.1097/00006231-198702000-00003


Related references

Radiopharmaceuticals and the Medicines Act. Nuclear Medicine Communications 8(11): 941-943, 1987

Radiology now. Radiopharmaceuticals and the Medicines Act. British Journal of Radiology 47(563): 741, 1974

Does consumer medicines interest reflect medicines use? An observational study comparing medicines call center queries with medicines use. Research in Social and Administrative Pharmacy 15(4): 440-447, 2019

Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals. European Journal of Nuclear Medicine and Molecular Imaging 41(11): 2005-2007, 2014

Drug interaction with radiopharmaceuticals: Effect on the labeling of red blood cells with technetium-99m and on the bioavailability of radiopharmaceuticals. Brazilian Archives of Biology & Technology 45(Special Issue): 143-149, 2002

Radiopharmaceuticals based on monoclonal antibodies. Radiopharmaceuticals Drafting Group and ad hoc Working Party on Biotechnology/Pharmacy. Pharmacology & Toxicology 69(3): 218-222, 1991

Cysteine, a chelating moiety for synthesis of technetium-99m radiopharmaceuticals: II. Attempt to synthesize renal tubular radiopharmaceuticals. International Journal of Radiation Applications and Instrumentation. Part B Nuclear Medicine and Biology 17(8): 757-762, 1990

Quality control of radiopharmaceuticals (II): evaluation of radioactive impurities in radiopharmaceuticals. Kaku Igaku. Japanese Journal of Nuclear Medicine 17(6): 723-728, 1980

Radiopharmaceuticals 1994. Nil desperandum. European Association of Nuclear Medicine Committees on Radiopharmaceuticals and Positron Emission Tomography. European Journal of Nuclear Medicine 22(6): 563-570, 1995

EEC directives and guidelines applicable to radiopharmaceuticals--1993. Status quo with particular emphasis on the registration of radiopharmaceuticals which were on the market prior to January 1992. European Journal of Nuclear Medicine 20(8): 712-715, 1993

Risk assessment and economic impact analysis of the implementation of new European legislation on radiopharmaceuticals in Italy: the case of the new monograph chapter Compounding of Radiopharmaceuticals (PHARMEUROPA, Vol. 23, No. 4, October 2011). Current Radiopharmaceuticals 6(4): 208-214, 2014

Are sugars-free medicines more erosive than sugars-containing medicines? An in vitro study of paediatric medicines with prolonged oral clearance used regularly and long-term by children. International Journal of Paediatric Dentistry 17(4): 231-238, 2007

Estimation of frequency, population doses and stochastic risks in medical uses of radiopharmaceuticals in Japan, 1982. 1. The number of medical examinations using radiopharmaceuticals. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 48(7): 911-920, 1988

Estimation of population doses from medical uses of radiopharmaceuticals in Japan, 1977. I. The number of medical examinations using radiopharmaceuticals. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 39(3): 267-276, 1979

Endotoxin detection in radiopharmaceuticals iii. limulus test assessment using radiopharmaceuticals correlation with the rabbit pyrogen test. International Journal of Nuclear Medicine and Biology 12(6): 477-482, 1986